saflutan 15 µg/1 ml kapi za oči, rastvor u jednodoznom spremniku
inspirehl d.o.o. - тафлупрост - kapi za oči, rastvor u jednodoznom spremniku - 15 µg/1 ml - 1 ml rastvora sadrži: 15 mcg tafluprosta
trusopt 20 mg/1 ml kapi za oči, rastvor
inspirehl d.o.o. - dorzolamid - kapi za oči, rastvor - 20 mg/1 ml - 1 ml kapi za oči, rastvora sadrži: 20 mg dorzolamida (u obliku dorzolamidhidrohlorida)
cosopt 20 mg/1 ml+ 5 mg/1 ml kapi za oči , rastvor
inspirehl d.o.o. - dorzolamid, timolol - kapi za oči , rastvor - 20 mg/1 ml+ 5 mg/1 ml - 1 ml kapi za oči, rastvora sadrži 20 mg dorzolamid (u obliku dorzolamidhidrohlorida) + 5 mg timolol (u obliku timololmaleata)
compactflo evolution, d 901 lilliput 1, d 902 lilliput 2, d 903 avant, d 905 eos i inspire
boston medical d.o.o., zagreb - oksigenatori za upotrebu u izvantjelesnoj cirkulaciji kao uređaj za zamjenu funkcije pluća
mguard koronarni stent
dispomed promet d.o.o., zagreb - koronarni stent sa košuljicom za poboljšanje luminalnog promjera koronarnih arterijskih žila
breyanzi
bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastična sredstva - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.